Quality of life and behavioral follow-up study of Head Start i pediatric brain tumor survivors Journal Article


Authors: Sands, S. A.; Pasichow, K. P.; Weiss, R.; Garvin, J.; Gardner, S.; Dunkel, I. J.; Finlay, J. L.
Article Title: Quality of life and behavioral follow-up study of Head Start i pediatric brain tumor survivors
Abstract: To evaluate the Quality of Life (QoL) and Social-Emotional/Behavioral functioning of survivors treated on the "Head Start I" protocol at participating medical centers across the United States between 1991 and 1997. Parents of 25 of 27 (92.5%) patients completed the Child Health Questionnaire PF-50 (CHQ), to assess their child's QoL, along with the Behavior Assessment System for Children (BASC), to assess their social-emotional/behavioral functioning, after a mean follow-up of 5.7 years (range 13-96 months). Nineteen (76%) of the 25 parents subsequently completed the same instruments after a mean of 11.6 years (range 90-181 months), three (12%) patients died of disease and three (12%) were lost to follow-up. Mean Physical and Psychosocial QoL Summary Scores on the CHQ at Time 1 (T1) and Time 2 (T2) were within the normal range. Of the ten individual means for CHQ subscales, nine were within normal limits with the exception of Parental Emotional Impact at T1 and General Health at T2. Additionally, mean scores on the BASC at T1 and T2 were within normal limits for Externalizing and Internalizing Behaviors as well as Adaptive Skills. Serial analyses between T1 and T2 revealed non-significant changes over time with the exception of decreased General Health on the CHQ. The lack of QoL and Social-Emotional/Behavioral deficits suggests that the Head Start I protocol, involving intensive induction followed by myeloablative chemotherapy and autologous hematopoietic cell rescue in order to avoid or delay cranial irradiation, provides encouraging pilot data warranting continued monitoring. © 2010 Springer Science+Business Media, LLC.
Keywords: adolescent; cancer chemotherapy; child; clinical article; controlled study; school child; cancer surgery; cisplatin; united states; brain tumor; follow up; quality of life; multiple cycle treatment; etoposide; cyclophosphamide; vincristine; clinical protocol; patient assessment; patient monitoring; late effects; cancer survivor; cancer center; myeloablative conditioning; recombinant granulocyte colony stimulating factor; emotionality; autologous hematopoietic stem cell transplantation; child health; social behavior; behavioral; head start; pediatric brain tumor; social-emotional
Journal Title: Journal of Neuro-Oncology
Volume: 101
Issue: 2
ISSN: 0167-594X
Publisher: Springer  
Date Published: 2011-01-01
Start Page: 287
End Page: 295
Language: English
DOI: 10.1007/s11060-010-0260-3
PROVIDER: scopus
PUBMED: 20526792
DOI/URL:
Notes: --- - "Export Date: 4 March 2011" - "CODEN: JNODD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel